Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

Published: May 2016
No. of Pages: 205

Price: Single User License: US $ 2500
Corporate User License: US $ 7500

GlobalData's clinical trial report, "Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Reasons to buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Systemic Sclerosis (Scleroderma) 29
May 25, 2016: Cytori Fully Enrolls Pivotal U.S. Phase III Scleroderma Trial 29
May 17, 2016: European Scleroderma Trial Investigating Cytori Cell Therapy to Be Presented in Japan 29
Apr 27, 2016: Cytori Announces Timing for Full Enrollment in U.S. Phase III Scleroderma Trial 30
Apr 12, 2016: Corbus Pharmaceuticals Receives FDA Approval for Open-Label Extension to Its Phase 2 Trial of Resunab for Systemic Sclerosis 30
Mar 24, 2016: Cytori provides Update on Its U.S. Phase III Scleroderma Trial 31
Mar 15, 2016: ProMetic announces the addition of scleroderma to PBI-4050 targeted indications 31
Clinical Trial Profile Snapshots 33
Appendix 202
Abbreviations 202
Definitions 202
Research Methodology 203
Secondary Research 203
About GlobalData 204
Contact Us 204
Disclaimer 204
Source 205

List of Tables

Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials, G7 Countries (%), 2016* 14
Systemic Sclerosis (Scleroderma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Systemic Sclerosis (Scleroderma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials, E7 Countries (%), 2016* 17
Systemic Sclerosis (Scleroderma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Systemic Sclerosis (Scleroderma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials, G7 Countries (%), 2016* 14
Systemic Sclerosis (Scleroderma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Systemic Sclerosis (Scleroderma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Systemic Sclerosis (Scleroderma) to Immunology Clinical Trials, E7 Countries (%), 2016* 17
Systemic Sclerosis (Scleroderma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Systemic Sclerosis (Scleroderma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Systemic Sclerosis (Scleroderma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 203

Published By: GlobalData
Product Code: GlobalData34669

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Tryptophan Market 2018, Forecast to 2023
Tryptophan (Trp) is an amino acid. For many organisms (including humans), tryptophan is an essential amino acid and cannot be synthesized by the organism. Tryptophan can be found in various fields of the chemical, animal feed and pharmaceutical indu...
Global Tryptophan Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Tryptophan (Trp) is an amino acid. For many organisms (including humans), tryptophan is an essential amino acid and cannot be synthesized by the organism. Tryptophan can be found in various fields of the chemical, animal feed and pharmaceutical indu...
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Minocycline Hydrochloride Market 2018, Forecast to 2023
Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of i...
Global Minocycline Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of i...
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lysine Market 2018, Forecast to 2023
Lysine is an a-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. It is an essential amino acid for humans. Scope of the Report: This report focuses on the Lysine in global market, especially in North America, Europe and Asia-Pacific, S...
Global Lysine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Lysine is an a-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. It is an essential amino acid for humans. Scope of the Report: This report focuses on the Lysine in global market, especially in North America, Europe and Asia-Pacific, S...
Global Depression Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2023
Depression is a mental health issue. Its a condition that starts most often in early adulthood. Its also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain ma...
Global Emollient Market Research Report 2018
This report studies the global Emollient market status and forecast, categorizes the global Emollient market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pa...
Global Rosuvastatin Calcium Market Research Report 2018
This report studies the global Rosuvastatin Calcium market status and forecast, categorizes the global Rosuvastatin Calcium market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North Am...
Global Liquid Biopsy Products Market Research Report 2018
This report studies the global Liquid Biopsy Products market status and forecast, categorizes the global Liquid Biopsy Products market size (value & volume) by key players, type, application, and region. This report focuses on the top players in Nort...

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option

Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: